Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intelgenx Technologies Corp (IGX.TO)

Intelgenx Technologies Corp (IGX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 38,808
  • Shares Outstanding, K 174,658
  • Annual Sales, $ 1,039 K
  • Annual Income, $ -9,927 K
  • 60-Month Beta 2.23
  • Price/Sales 29.40
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IGX.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date 05/09/24 [--]
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1850 +29.73%
on 04/25/24
0.2600 -7.69%
on 05/02/24
-0.0100 (-4.00%)
since 04/03/24
3-Month
0.1700 +41.18%
on 02/27/24
0.2600 -7.69%
on 05/02/24
+0.0250 (+11.63%)
since 02/01/24
52-Week
0.1350 +77.78%
on 10/31/23
0.3000 -20.00%
on 06/13/23
+0.0500 (+26.32%)
since 05/03/23

Most Recent Stories

More News
Stocks in play: IntelGenx Corp.

Announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients ...

IGX.TO : 0.2400 (unch)
CHANGES TO BOARD OF DIRECTORS OF GEEKCO

/CNW/ - Geekco Technologies Corporation (the "Corporation" or "Geekco") (TSXV: GKO) (OTCQB: GKOTF) is pleased to announce the appointments of André Godin and...

IGX.TO : 0.2400 (unch)
IGXT : 0.1619 (-9.30%)
GKO.VN : 0.065 (unch)
Stocks in play: IntelGenx Corp.

Announced that its previously undisclosed development candidate, Buprenorphine Buccal Film, for which ...

IGX.TO : 0.2400 (unch)
Stocks in play: IntelGenx Technologies Corp.

Announced that it will release its second-quarter 2022 financial results after market close on Thursday, ...

IGX.TO : 0.2400 (unch)
IntelGenx Announces Completion of Share Issuance in Payment of Principal and Interest on Debentures

SAINT LAURENT, Quebec, July 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces...

IGX.TO : 0.2400 (unch)
IGXT : 0.1619 (-9.30%)
IntelGenx to Report First Quarter 2022 Financial Results on May 12, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGX.TO : 0.2400 (unch)
IGXT : 0.1619 (-9.30%)
IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGX.TO : 0.2400 (unch)
IGXT : 0.1619 (-9.30%)
IntelGenx Reports Fourth Quarter and Full-Year 2021 Financial Results

SAINT LAURENT, Quebec, March 24, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today...

IGX.TO : 0.2400 (unch)
IGXT : 0.1619 (-9.30%)
IntelGenx to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, March 17, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGX.TO : 0.2400 (unch)
IGXT : 0.1619 (-9.30%)
Stocks in play: IntelGenx Corp.

Announced that its wholly-owned subsidiary, IntelGenx Corp. has received a third term loan in the amount ...

IGX.TO : 0.2400 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release...

See More

Key Turning Points

3rd Resistance Point 0.2400
2nd Resistance Point 0.2400
1st Resistance Point 0.2400
Last Price 0.2400
1st Support Level 0.2400
2nd Support Level 0.2400
3rd Support Level 0.2400

See More

52-Week High 0.3000
Last Price 0.2400
Fibonacci 61.8% 0.2370
Fibonacci 50% 0.2175
Fibonacci 38.2% 0.1980
52-Week Low 0.1350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar